europabio-logoeuropabio-logoeuropabio-logoeuropabio-logo
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • Events
  • Newsroom
    • News & Publications
    • Newsletter
    • Library
Become a member
✕

Towards an accurate accounting for carbon from biomass in the Product Environmental Footprint (PEF)

29/07/2022
POSITION PAPER
Bio-based products are products wholly or partly derived from renewable materials of biological origin (i.e. from plants, crops, trees, algae and biological waste). These products are used in a wide range of applications, such as energy, textile, plastics, pharmaceuticals, hygiene, food and many more.

We need a fairer method to account for the footprint of biogenic carbon and allocate it to the actors along the bioeconomy value chains.

Biogenic carbon in the current PEF rules
In the currently proposed methodology of the Product Environmental Footprint rules addressing biogenic carbon, there is no recognized benefit granted to the producers of biomass-derived products, compared to fossil ones.

In a cradle-to-grave approach, the biogenic uptake and emissions of CO2 from disposal are balanced. Therefore, in such a cradle-to-grave approach, biomass derived products will not receive any CO2 burden when they are disposed of, while fossil products will receive a CO2 burden in case of incineration.

However, in a cradle-to-gate life-cycle analysis using PEF methodology, biomass-derived products will not receive any credit for the fact that CO2 was removed from the atmosphere during photosynthesis and plant growth. Whereas in LCA (ISO 14067, EN 15804 and other LCA standards1) biogenic CO2 uptake in biomass-derived products shall be addressed.

When the use of the product cannot be singled out - like platform chemicals which are used for a range of different other products or intermediates -, the manufacturers need to supply a cradle-to-gate LCA. Accordingly, there will be no CO2 credit for bio-based raw materials calculated at the gate of the product. It will look like there is hardly any benefit from producing biomass-derived products if any at all, compared to fossil based.

The same “accounting” problem appears when biomass feedstock is blended with fossil feedstock, like in mass balance scenarios. There will hardly be any difference in greenhouse gas footprints as long as a cradle-to-gate assessment is used for life-cycle inventories and for full LCA where other forms of end-of life approaches than incineration are applied. Additionally with the current approach, the use of the products in long-lasting applications, investment goods and others are not considered as an actual removal of biogenic CO2.

Read the full position here.

Towards an accurate accounting for carbon from biomass in the Product Environmental Footprint (PEF)


Download
Share
Alexandra Simionca
Alexandra Simionca

Related posts

28/02/2023

How do we live in a bioeconomy? EuropaBio at the Swedish EU Council Presidency conference


Read more
23/02/2023

EuropaBio Response to Public Consultation on Horizon Europe – interim evaluation


Read more
17/02/2023

Inter-association letter to raise our concern about the proposed definition of “natural polymers” in the REACH restriction of microplastics


Read more
01/02/2023

Joint Statement: The Data Act is a leap into the unknown


Read more

Important links

  • Unlocking the Potential of Biotechnology Innovation for Patients
  • Vision, clarity and enabling – the drivers for Europe’s biomanufacturing future

Categories in our Newsroom

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
EuropaBio-Logo-White

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkLegal & Cookies